• Oisin Houghton
  • W. Glenn McCluggage


This chapter outlines the anatomy, clinical presentation, and relevant clinical investigations. Details of both non-neoplastic and neoplastic pathological conditions affecting this organ site are given. Clinical considerations in obtaining the diagnostic biopsy and therapeutic resection specimens are outlined, with details of their handling and dissection in the histopathology laboratory. This is correlated with relevant histopathology reports, giving summary core prognostic and patient management items. Current WHO and TNM classifications are referenced.


Cervical Cancer Human Papilloma Virus Local Excision Cervical Intraepithelial Neoplasia Pelvic Lymph Node 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Allen DC. Histopathology reporting. Guidelines for surgical cancer. London: Springer; 2006.Google Scholar
  2. Allen DC, Cameron RI. Histopathology specimens: clinical, pathological and laboratory aspects. 1st ed. Berlin/Heidelberg: Springer; 2004.Google Scholar
  3. Fox H, Wells M, editors. Haines and Taylor: obstetrical and gynaecological pathology. 5th ed. Edinburgh: Churchill Livingstone; 2003.Google Scholar
  4. Heatley MK. Dissection and reporting of the organs of the female genital tract. J Clin Pathol. 2008;61:241–57.PubMedCrossRefGoogle Scholar
  5. Histopathology reporting in cervical screening. NHSCSP publication, No 10; Dec 2011.Google Scholar
  6. Kurman RJ, Amin MB. Protocol for the examination of specimens from patients with carcinoma of the cervix. Arch Pathol Lab Med. 1999;123:55–66.PubMedGoogle Scholar
  7. Kurman RJ, Norris HJ, Wilkinson E. Tumors of the cervix, vagina and vulva. In: Atlas of tumor pathology, 3rd series. Fascicle 4. Washington: AFIP; 1992.Google Scholar
  8. McCluggage WG, Hirschowitz L, Ganesan R, Kehoe S, Nordin A. Which staging system to use for gynaecological cancers: a survey with recommendations for practice in the UK. J Clin Pathol. 2010;63:768–70.PubMedCrossRefGoogle Scholar
  9. Pecorelli S. FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix and endometrium. Int J Gynecol Obstet. 2009;105:103–4.CrossRefGoogle Scholar
  10. Robboy SJ, Bentley RC, Russell R, Anderson MC, Mutter GL, Prat J. Pathology of the female reproductive tract. 2nd ed. London: Churchill Livingstone/Elsevier; 2009.Google Scholar
  11. Scurry J, Patel K, Wells M. Gross examination of uterine specimens. J Clin Pathol. 1993;46:388–93.PubMedCrossRefGoogle Scholar
  12. Tavassoli F, Devilee P. WHO classification of tumours. Pathology and genetics. Tumours of the breast and female genital organs. Lyon: IARC Press; 2003.Google Scholar
  13. The Royal College of Pathologists and the NHS Cervical Screening Programme. Cancer datasets (vulval neoplasms, cervical neoplasia, endometrial cancer, uterine sarcomas, neoplasms of the ovaries and fallopian tubes and primary carcinoma of the peritoneum), and tissue pathways for gynaecological pathology. Accessed at Accessed date Dec 2011.
  14. Wittekind C, Greene L, Hutter RVP, Klimfinger M, Sobin LH. TNM atlas: illustrated guide to the TNM/pTNM classification of malignant tumours. 5th ed. Berlin/Heidelberg: Springer; 2005.Google Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  1. 1.Histopathology LaboratoryInstitute of Pathology, Royal Victoria Hospital, Belfast Health and Social Care TrustBelfastUK

Personalised recommendations